Incidence and Risk Factors of Hypokalemia in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Collection

ABSTRACT Autologous peripheral blood stem cell (APBSC) collection is a standard procedure for patients with multiple myeloma (MM) undergoing hematopoietic stem cell transplantation. Hypokalemia is a frequently observed but underappreciated complication during apheresis, with limited evidence on its incidence and risk factors. To determine the incidence of hypokalemia following APBSC collection in MM patients and to identify independent risk factors. This retrospective cohort study consecutively enrolled 109 MM patients who underwent their first APBSC collection at Union Hospital, Fujian Medical University, between January 2018 and December 2022. All patients received prophylactic potassium supplementation during collection. Patients were stratified by serum potassium measured 2 h postprocedure: hypokalemia (< 3.5 mmol/L; n = 59) and normokalemia (3.5–5.0 mmol/L; n = 50). Variables with p < 0.10 in univariate analysis were entered into multivariable logistic regression with backward elimination. Post‐APBSC serum potassium was significantly lower than baseline (3.46 ± 0.43 vs. 3.85 ± 0.22 mmol/L; p < 0.001). Hypokalemia developed in 59 patients (54.1%): 48 mild (81.4%), nine moderate (15.3%), and two severe (3.4%). Three independent predictors were identified by multivariable analysis: higher body mass index (BMI) (OR 1.217; 95% CI 1.030–1.439; p = 0.021), higher hematocrit (OR 1.119; 95% CI 1.032–1.213; p = 0.006), and lower preprocedure serum potassium (OR 1.43 per 0.1 mmol/L decrease; 95% CI 1.15–1.78; p = 0.001). The model demonstrated adequate calibration (Hosmer–Lemeshow p = 0.635) and explained 24.6% of variance (Nagelkerke R 2 = 0.246). Hypokalemia affects over half of MM patients undergoing APBSC collection. Preprocedure risk factors (BMI, hematocrit, baseline potassium) may help identify high‐risk patients for whom intensified electrolyte monitoring and individualized supplementation strategies are warranted.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Apheresis
Published
2026-11-01
DOI
https://doi.org/10.1002/jca.70205
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Incidence and Risk Factors of Hypokalemia in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Collection

Zhiyi Zheng, Biyu Wei, Jianfang Liu, Qinghua Huang et al.
Journal of Clinical Apheresis
Multiple Myeloma Research and Treatments
article

Incidence and Risk Factors of Hypokalemia in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Collection

Zhiyi Zheng, Biyu Wei, Jianfang Liu, Qinghua Huang, Jingyi Xia
article en

Abstract

ABSTRACT Autologous peripheral blood stem cell (APBSC) collection is a standard procedure for patients with multiple myeloma (MM) undergoing hematopoietic stem cell transplantation. Hypokalemia is a frequently observed but underappreciated complication during apheresis, with limited evidence on its incidence and risk factors. To determine the incidence of hypokalemia following APBSC collection in MM patients and to identify independent risk factors. This retrospective cohort study consecutively enrolled 109 MM patients who underwent their first APBSC collection at Union Hospital, Fujian Medical University, between January 2018 and December 2022. All patients received prophylactic potassium supplementation during collection. Patients were stratified by serum potassium measured 2 h postprocedure: hypokalemia (< 3.5 mmol/L; n = 59) and normokalemia (3.5–5.0 mmol/L; n = 50). Variables with p < 0.10 in univariate analysis were entered into multivariable logistic regression with backward elimination. Post‐APBSC serum potassium was significantly lower than baseline (3.46 ± 0.43 vs. 3.85 ± 0.22 mmol/L; p < 0.001). Hypokalemia developed in 59 patients (54.1%): 48 mild (81.4%), nine moderate (15.3%), and two severe (3.4%). Three independent predictors were identified by multivariable analysis: higher body mass index (BMI) (OR 1.217; 95% CI 1.030–1.439; p = 0.021), higher hematocrit (OR 1.119; 95% CI 1.032–1.213; p = 0.006), and lower preprocedure serum potassium (OR 1.43 per 0.1 mmol/L decrease; 95% CI 1.15–1.78; p = 0.001). The model demonstrated adequate calibration (Hosmer–Lemeshow p = 0.635) and explained 24.6% of variance (Nagelkerke R 2 = 0.246). Hypokalemia affects over half of MM patients undergoing APBSC collection. Preprocedure risk factors (BMI, hematocrit, baseline potassium) may help identify high‐risk patients for whom intensified electrolyte monitoring and individualized supplementation strategies are warranted.

Journal of Clinical ApheresisVol. 41(6)
Fujian Medical University (CN), First Affiliated Hospital of Xiamen University (CN), Union Hospital (CN)
Openalex Percentile: Top 11%
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon